Form 8-K - Current report:
SEC Accession No. 0001193125-25-182451
Filing Date
2025-08-18
Accepted
2025-08-18 11:43:10
Documents
20
Period of Report
2025-08-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d899078d8k.htm   iXBRL 8-K 29260
2 EX-1.1 d899078dex11.htm EX-1.1 191707
3 EX-4.2 d899078dex42.htm EX-4.2 91850
4 EX-4.3 d899078dex43.htm EX-4.3 37810
5 EX-4.4 d899078dex44.htm EX-4.4 37762
6 EX-5.1 d899078dex51.htm EX-5.1 15648
10 GRAPHIC g899078g0814073159904.jpg GRAPHIC 2813
11 GRAPHIC g899078g0815075135374.jpg GRAPHIC 2409
12 GRAPHIC g899078g0815080101699.jpg GRAPHIC 2409
  Complete submission text file 0001193125-25-182451.txt   621218

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA zts-20250811.xsd EX-101.SCH 2842
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE zts-20250811_lab.xml EX-101.LAB 17233
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zts-20250811_pre.xml EX-101.PRE 10807
22 EXTRACTED XBRL INSTANCE DOCUMENT d899078d8k_htm.xml XML 3480
Mailing Address 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 10 SYLVAN WAY PARSIPPANY NJ 07054 973-822-7000
Zoetis Inc. (Filer) CIK: 0001555280 (see all company filings)

EIN.: 460696167 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35797 | Film No.: 251226965
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)